The current state of GPCR-based drug discovery to treat metabolic disease.

Kyle W SloopPaul J EmmersonMichael A StatnickFrancis S Willard

Published in: British journal of pharmacology (2018)

This article is part of a themed section on Molecular Pharmacology of GPCRs. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.21/issuetoc.

Keyphrases

drug discovery
benign prostatic hyperplasia
lower urinary tract symptoms